墨西哥城HIV传播簇内治疗前耐药传播动态
基于墨西哥城2447例未治疗HIV感染者pol序列,用HIV-TRACE推断传播网络。治疗前耐药率14.8%,NNRTI耐药9.6%;39%序列形成326个簇,簇内18%共享耐药突变,以K103N/S为主,网络按年龄和行政区聚集。
要点
- 治疗前HIV耐药率14.8%,NNRTI耐药9.6%。
- 39%序列形成传播簇,簇内18%共享耐药突变。
- 共享K103N/S者更年轻,耐药传播呈年龄和地理聚集。
核心结论
- 墨西哥城HIV遗传网络中存在与年龄和地理相关的耐药突变传播,需持续监测和针对性干预。
研究设计与样本
- 对2016年4月至2018年6月墨西哥城最大HIV诊所2447例启动ART前个体的HIV pol序列进行下一代测序。
- 用Stanford算法以≥20%阈值估计治疗前耐药,用HIV-TRACE以遗传距离<1.5%推断传播网络。
主要发现
- 总体治疗前耐药率为14.8%(95% CI 13.4%-16.2%),NNRTI耐药率为9.6%(8.5%-10.8%)。
- 963/2447(39%)序列与至少一条其他序列存在推定连接,形成326个簇(2-20人)。
- 网络按年龄和行政区聚集(P < 0.001);聚类个体更年轻(aOR=0.96,95% CI 0.95-0.97,P < 0.001),女性可能性更低(aOR=0.46,95% CI 0.28-0.75,P=0.002)。
- 聚类个体中175/963(18%)共享耐药突变(涉及66簇),其中66/175(38%)共享K103N/S(24簇)。
- 75个行政区中8个容纳了65%的共享耐药突变者;共享K103N者更年轻(aOR=0.93,95% CI 0.88-0.98,P=0.003)。
临床怎么用
- 对墨西哥城新诊断HIV者在启动ART前应进行耐药检测,尤其关注年轻人群和特定行政区。
- 利用传播网络监测耐药突变聚集,指导针对性干预和持续监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pretreatment HIV drug resistance (HIVDR) to NNRTIs has consistently increased in Mexico City during the last decade. OBJECTIVES: To infer the HIV genetic transmission network in Mexico City to describe the dynamics of the local HIV epidemic and spread of HIVDR. PATIENTS AND METHODS: HIV pol sequences were obtained by next-generation sequencing from 2447 individuals before initiation of ART at the largest HIV clinic in Mexico City (April 2016 to June 2018). Pretreatment HIVDR was estimated using the Stanford algorithm at a Sanger-like threshold (≥20%). Genetic networks were inferred with HIV-TRACE, establishing putative transmission links with genetic distances <1.5%. We examined demographic associations among linked individuals with shared drug resistance mutations (DRMs) using a ≥ 2% threshold to include low-frequency variants. RESULTS: Pretreatment HIVDR reached 14.8% (95% CI 13.4%-16.2%) in the cohort overall and 9.6% (8.5%-10.8%) to NNRTIs. Putative links with at least one other sequence were found for 963/2447 (39%) sequences, forming 326 clusters (2-20 individuals). The inferred network was assortative by age and municipality (P < 0.001). Clustering individuals were younger [adjusted OR (aOR) per year = 0.96, 95% CI 0.95-0.97, P < 0.001] and less likely to include women (aOR = 0.46, 95% CI 0.28-0.75, P = 0.002). Among clustering individuals, 175/963 (18%) shared DRMs (involving 66 clusters), of which 66/175 (38%) shared K103N/S (24 clusters). Eight municipalities (out of 75) harboured 65% of persons sharing DRMs. Among all persons sharing DRMs, those sharing K103N were younger (aOR = 0.93, 95% CI 0.88-0.98, P = 0.003). CONCLUSIONS: Our analyses suggest age- and geographically associated transmission of DRMs within the HIV genetic network in Mexico City, warranting continuous monitoring and focused interventions.
引用
- Matías-Florentino M, Chaillon A, Ávila-Ríos S, et al. Pretreatment HIV drug resistance spread within transmission clusters in Mexico City. J Antimicrob Chemother. 2020. PMID: 31819984. doi:10.1093/jac/dkz502
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。